top of page

Ask the experts: Psilocybin and MDMA Research

In this webinar, two of the world’s leading psychedelic research experts; Dr Ben Sessa and Dr Meg Spriggs, answer questions on the therapeutic applications of MDMA and psilocybin! Who is Dr Ben Sessa? Dr Ben Sessa is a consultant child and adolescent psychiatrist who has worked with young people and adults in the field of addictions and trauma-related psychiatry for over 20 years. For the last 15 years, he has been at the forefront of psychedelic research in the UK through his affiliations with Bristol University and Imperial College London, under the auspices of Professor David Nutt. He has taken part as a study doctor and as a healthy subject both receiving and / or administering MDMA, psilocybin, LSD, DMT and ketamine in multiple UK research studies. He runs one of the first UK-based medical cannabis prescribing clinics. Dr Sessa is the Chief Medical Officer at AWAKN Life Sciences, a new start-up company opening Europe’s first psychedelic medical clinic, which will be providing psychedelic therapies, therapist training courses and conducting independent research. He is the co-founder and former president of Europe’s largest psychedelic conference, Breaking Convention. Who is Dr Meg Spriggs? Dr. Meg Spriggs completed her PhD in psychology at the University of Auckland, New Zealand. Following her passions for neuroscience and mental health, she joined the team at the Centre for Psychedelic Research at Imperial College London in 2018 where she works as a co-ordinator and guide on studies of psilocybin in healthy volunteers and patient populations. She is one of the lead researchers on the centre’s trial looking at psilocybin in the treatment of anorexia nervosa; a devastating disorder with no currently approved treatments. This webinar was recorded during the Student Psychedelic Conference which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do is join the Drug Science Mailing List. Drug Science is the leading independent scientific body on drugs in the UK. We rely on donations to provide clear, evidence-based information without political or commercial interference. Drug Science webinars are free, and always will be, so if you’d like to support us then please consider joining the Drug Science Community

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page